| Cash Flow | 2025-09-30 |
|---|---|
| Net income | 32,482 |
| Provision for credit loss expense | 24,350 |
| Depreciation and amortization of premises and equipment, operating leases assets, core deposit intangible, and mortgage servicing rights | 7,089 |
| Accretion of securities, deferred loan fees and costs, net yield and credit mark on acquired loans, and unearned income | 8,211 |
| Net amortization of deferred costs on borrowings | 228 |
| Net realized (gains) losses on sales of available-for-sale securities | 397 |
| Net realized and unrealized gains on equity securities | 982 |
| (gain) loss on sale of loans held for sale | -262 |
| Net (gains) losses on dispositions of premises and equipment and foreclosed assets | 158 |
| Proceeds from sale of loans receivable | 17,738 |
| Origination of loans held for sale | 17,293 |
| Income on bank owned life insurance | 2,531 |
| Gain on bank owned life insurance (death benefit proceeds in excess of cash surrender value) | 180 |
| Restricted stock compensation expense | 1,891 |
| Accrued interest receivable and other assets | 7,831 |
| Accrued interest payable, lease liabilities, and other liabilities | -7,578 |
| Net cash provided by operating activities | 38,879 |
| Proceeds from maturities, prepayments and calls of available-for-sale securities | 90,044 |
| Proceeds from sales of available-for-sale securities | 258,295 |
| Purchase of available-for-sale securities | 168,155 |
| Proceeds from maturities, prepayments and calls of held-to-maturity securities | 57,574 |
| Proceeds from sale of equity securities | 1,164 |
| Purchase of equity securities | 231 |
| Proceeds from sales of loans classified as portfolio loans | 23,215 |
| Net increase in loans receivable | 227,654 |
| Proceeds from death benefit of bank owned life insurance policies | 884 |
| Net cash from business combinations | 27,403 |
| Purchase of fhlb, other equity, and restricted equity interests | -4,061 |
| Purchase of premises and equipment | 6,203 |
| Proceeds from the sale of premises and equipment and foreclosed assets | 1,689 |
| Net cash provided (used) by investing activities | 62,086 |
| Net increase in checking, money market and savings accounts | 155,024 |
| Net increase (decrease) in certificates of deposit | 10,904 |
| Purchase of treasury stock | 333 |
| Cash dividends paid, common stock | 12,885 |
| Cash dividends paid, preferred stock | 3,226 |
| Net change in short-term borrowings | -255,396 |
| Net cash provided (used) by financing activities | -105,912 |
| Net increase (decrease) in cash and cash equivalents | -4,947 |
| Cash and cash equivalents at beginning of period | 443,035 |
| Cash and cash equivalents at end of period | 438,088 |
CNB FINANCIAL CORP PA (CCNEP)
CNB FINANCIAL CORP PA (CCNEP)